Primo Brands (PRMB) investor relations material

Executive summary

• Third consecutive quarter of comparable net sales growth; momentum broadened across direct delivery and retail, with bottled-water dollar-share gains.

• Q3 comparable net sales rose 3.3% to $1,821.0M; Comparable Adjusted EBITDA increased 1.6% to $411.0M.

• Priorities included customer service, sales growth, financial objectives and shareholder value; leadership simplification sharpened accountability, with further execution work remaining.

• Growth priorities include pricing, premium offerings, direct-delivery experience, productivity, SG&A efficiency, deleveraging and strategic bolt-on M&A.

Financial highlights

• Reported net sales were $1,821.0M, up 3.1%; comparable sales growth comprised 2.9% organic and 0.4% inorganic growth, with 5.9% price/mix offset by a 2.6% volume decline.

• Comparable Adjusted EBITDA rose to $411.0M from $404.5M; margin declined 40 bps to 22.6% from 23.0%.

• Continuing-operations net income increased to $124.5M from $40.5M; diluted EPS was $0.34 versus $0.11.

• Q3 gross profit rose 4.9% to $553.9M and gross margin increased to 30.4% from 29.9%; SG&A fell 7.8% to $316.3M.

• 9M Adjusted EBITDA was $1,102.0M versus $1,112.7M; 9M gross margin declined to 29.9% from 31.1%.

Outlook and guidance

• FY 2026 comparable net sales growth is expected at ~3%, the midpoint of the prior 2%–4% range; Adjusted EBITDA is expected near the lower end of the $1,465M–$1,515M range.

• Adjusted Free Cash Flow guidance remains $790M–$810M; base capex target remains 4% of net sales.

• 2027 outlook calls for Adjusted EBITDA and Adjusted Free Cash Flow growth and lower net leverage; formal guidance, including growth magnitude, is planned for February.

• 2027 growth drivers include carryover pricing, revenue growth management, immediate-consumption mix, premium brands and new productivity initiatives.

• Q4 workforce and route-productivity actions carry a one-time charge, with most benefits expected in 2027; net leverage below 3x is targeted during 2027.